These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 11477165
1. Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential. Dogra G, Ward N, Croft KD, Mori TA, Barrett PH, Herrmann SE, Irish AB, Watts GF. Nephrol Dial Transplant; 2001 Aug; 16(8):1626-30. PubMed ID: 11477165 [Abstract] [Full Text] [Related]
2. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Mori TA, Croft KD, Puddey IB, Beilin LJ. Anal Biochem; 1999 Mar 01; 268(1):117-25. PubMed ID: 10036170 [Abstract] [Full Text] [Related]
3. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Handelman GJ, Walter MF, Adhikarla R, Gross J, Dallal GE, Levin NW, Blumberg JB. Kidney Int; 2001 May 01; 59(5):1960-6. PubMed ID: 11318969 [Abstract] [Full Text] [Related]
4. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA. Circulation; 1997 Nov 18; 96(10):3314-20. PubMed ID: 9396422 [Abstract] [Full Text] [Related]
5. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Devaraj S, Hirany SV, Burk RF, Jialal I. Clin Chem; 2001 Nov 18; 47(11):1974-9. PubMed ID: 11673365 [Abstract] [Full Text] [Related]
6. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome]. Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M. Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472 [Abstract] [Full Text] [Related]
7. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB. Anal Biochem; 1999 Aug 01; 272(2):209-15. PubMed ID: 10415090 [Abstract] [Full Text] [Related]
8. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, Croft K, Beilin L. Hypertension; 2001 Oct 01; 38(4):803-8. PubMed ID: 11641290 [Abstract] [Full Text] [Related]
9. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress. Nourooz-Zadeh J, Cooper MB, Ziegler D, Betteridge DJ. Biochem Biophys Res Commun; 2005 May 13; 330(3):731-6. PubMed ID: 15809058 [Abstract] [Full Text] [Related]
10. Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer's disease. Kim KM, Jung BH, Paeng KJ, Kim I, Chung BC. Brain Res Bull; 2004 Jul 30; 64(1):47-51. PubMed ID: 15275956 [Abstract] [Full Text] [Related]
12. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Montero A, Munger KA, Khan RZ, Valdivielso JM, Morrow JD, Guasch A, Ziyadeh FN, Badr KF. Kidney Int; 2000 Nov 30; 58(5):1963-72. PubMed ID: 11044216 [Abstract] [Full Text] [Related]
13. Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats. Roberts LJ, Reckelhoff JF. Biochem Biophys Res Commun; 2001 Sep 14; 287(1):254-6. PubMed ID: 11549283 [Abstract] [Full Text] [Related]
14. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. Schweer H, Watzer B, Seyberth HW, Nüsing RM. J Mass Spectrom; 1997 Dec 14; 32(12):1362-70. PubMed ID: 9423285 [Abstract] [Full Text] [Related]
15. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes. Taylor AW, Bruno RS, Frei B, Traber MG. Anal Biochem; 2006 Mar 01; 350(1):41-51. PubMed ID: 16448621 [Abstract] [Full Text] [Related]
16. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Mori TA, Puddey IB, Burke V, Croft KD, Dunstan DW, Rivera JH, Beilin LJ. Redox Rep; 2000 Mar 01; 5(1):45-6. PubMed ID: 10905544 [Abstract] [Full Text] [Related]
18. 8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnoea patients. Cherneva RV, Cherneva ZV, Georgiev OB, Petrova DS, Petrova JI. Clin Physiol Funct Imaging; 2017 Nov 01; 37(6):695-702. PubMed ID: 27256793 [Abstract] [Full Text] [Related]
19. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L. Free Radic Biol Med; 2004 Sep 01; 37(5):724-32. PubMed ID: 15288129 [Abstract] [Full Text] [Related]
20. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. Davies SS, Zackert W, Luo Y, Cunningham CC, Frisard M, Roberts LJ. Anal Biochem; 2006 Jan 15; 348(2):185-91. PubMed ID: 16309621 [Abstract] [Full Text] [Related] Page: [Next] [New Search]